Johnson & Johnson announced Wednesday that its vaccine candidate for Covid-19 will enter Phase 3 trials, the fourth to do so. The speed of vaccine development is remarkable, and credit goes to scientific advances and some smart government decisions.
Johnson & Johnson announced Wednesday that its vaccine candidate for Covid-19 will enter Phase 3 trials, the fourth to do so. The speed of vaccine development is remarkable, and credit goes to scientific advances and some smart government decisions.